PELIZZARO, FILIPPO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.439
AS - Asia 1.026
EU - Europa 960
SA - Sud America 268
AF - Africa 203
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 12
Totale 3.924
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.324
SG - Singapore 394
IT - Italia 326
HK - Hong Kong 240
BR - Brasile 204
CN - Cina 150
DE - Germania 122
PL - Polonia 66
FI - Finlandia 58
NL - Olanda 53
FR - Francia 48
GB - Regno Unito 42
VN - Vietnam 42
RU - Federazione Russa 34
MX - Messico 22
SE - Svezia 22
AT - Austria 20
EC - Ecuador 17
JP - Giappone 17
IN - India 16
ZA - Sudafrica 16
BE - Belgio 15
CA - Canada 13
LY - Libia 13
CH - Svizzera 12
CZ - Repubblica Ceca 12
ID - Indonesia 12
EG - Egitto 11
IE - Irlanda 11
TR - Turchia 11
IR - Iran 10
PH - Filippine 10
PY - Paraguay 10
TH - Thailandia 10
DO - Repubblica Dominicana 9
GN - Guinea 9
KR - Corea 9
CI - Costa d'Avorio 8
CO - Colombia 8
DK - Danimarca 8
LC - Santa Lucia 8
LU - Lussemburgo 8
RS - Serbia 8
RW - Ruanda 8
TJ - Tagikistan 8
UA - Ucraina 8
BS - Bahamas 7
GT - Guatemala 7
MA - Marocco 7
ME - Montenegro 7
MK - Macedonia 7
NE - Niger 7
NP - Nepal 7
SD - Sudan 7
UG - Uganda 7
XK - ???statistics.table.value.countryCode.XK??? 7
AR - Argentina 6
AZ - Azerbaigian 6
BO - Bolivia 6
CD - Congo 6
CG - Congo 6
DZ - Algeria 6
GM - Gambi 6
KE - Kenya 6
LA - Repubblica Popolare Democratica del Laos 6
PS - Palestinian Territory 6
PT - Portogallo 6
RO - Romania 6
TT - Trinidad e Tobago 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
AM - Armenia 5
BA - Bosnia-Erzegovina 5
BW - Botswana 5
BY - Bielorussia 5
CV - Capo Verde 5
HU - Ungheria 5
MD - Moldavia 5
MY - Malesia 5
PK - Pakistan 5
PR - Porto Rico 5
RE - Reunion 5
SN - Senegal 5
TN - Tunisia 5
UZ - Uzbekistan 5
ZM - Zambia 5
AU - Australia 4
CL - Cile 4
CR - Costa Rica 4
CW - ???statistics.table.value.countryCode.CW??? 4
DJ - Gibuti 4
EE - Estonia 4
ES - Italia 4
GA - Gabon 4
GE - Georgia 4
HN - Honduras 4
IQ - Iraq 4
KZ - Kazakistan 4
LB - Libano 4
MG - Madagascar 4
Totale 3.771
Salva come PNG Salva come JPEG
Città #
Singapore 241
Hong Kong 228
Ashburn 198
Fairfield 169
Chandler 111
Beijing 69
Santa Clara 69
Woodbridge 59
Munich 58
Houston 52
Padova 52
Boardman 50
Bytom 47
Cambridge 47
Seattle 36
Wilmington 29
New York 27
San Diego 27
Turku 27
Medford 25
Princeton 25
Milan 24
São Paulo 19
Ann Arbor 18
Los Angeles 17
Lappeenranta 16
Hefei 15
Nuremberg 15
Roxbury 15
Guangzhou 14
Helsinki 14
London 14
Arezzo 13
Ho Chi Minh City 13
Des Moines 12
Brooklyn 11
Tokyo 11
Frankfurt am Main 10
Hanoi 10
Verona 10
Villafranca Padovana 10
Cagliari 9
Conakry 9
Düsseldorf 9
Mexico City 9
Padua 9
Rome 9
Seoul 9
Vienna 9
Warsaw 9
Abidjan 8
Dushanbe 8
Kigali 8
Rio de Janeiro 8
Bologna 7
Cairo 7
Castries 7
Dublin 7
Johannesburg 7
Kampala 7
Nassau 7
Palermo 7
Quito 7
Venice 7
Baku 6
Belgrade 6
Istanbul 6
Kinshasa 6
Montreal 6
Niamey 6
Podgorica 6
Treviso 6
Tripoli 6
Asunción 5
Atlanta 5
Belo Horizonte 5
Boston 5
Brazzaville 5
Brussels 5
Chicago 5
Khartoum 5
Lausanne 5
Lusaka 5
Nairobi 5
Naples 5
Prague 5
Praia 5
San Juan 5
Shanghai 5
Stockholm 5
Tashkent 5
Amsterdam 4
Dakar 4
Djibouti 4
Falkenstein 4
Gdansk 4
Guatemala City 4
Guayaquil 4
Jakarta 4
Kuala Lumpur 4
Totale 2.290
Salva come PNG Salva come JPEG
Nome #
Capecitabine in advanced hepatocellular carcinoma: A multicenter experience 200
Monofocal hepatocellular carcinoma: How much does size matter? 155
SCCA-IgM in hepatocellular carcinoma patients treated with transarterial chemoembolization: gender-related differences 131
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 127
Liver histopathology in COVID-19 patients: A mono-Institutional series of liver biopsies and autopsy specimens 126
Pattern of macrovascular invasion in hepatocellular carcinoma 112
Boost: A phase 3 trial of sorafenib vs. best supportive care in first line treatment of hepatocellular carcinoma in patients with deteriorated liver function 104
Liquid biopsy in hepatocellular carcinoma: Where are we now? 101
The risk of malignancies in celiac disease—A literature review 93
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis 91
Autoimmune Atrophic Gastritis: The Role of miRNA in Relation to Helicobacter Pylori Infection 89
Management of hepatocellular carcinoma recurrence after liver transplantation 89
CiThroModel Improves Prediction of Symptomatic Venous Thromboembolism in Hospitalized Patients With Cirrhosis Without Hepatocellular Carcinoma 89
Coffee and hepatocellular carcinoma: Epidemiologic evidence and biologic mechanisms 88
Letter: is female sex really associated with better prognosis in hepatocellular carcinoma? 81
Circulating prostaglandin E2: a novel potential prognostic biomarker in patients with hepatocellular carcinoma 80
Gastric cancer screening in Western countries: A call to action 79
Liver resection versus radiofrequency ablation or trans-arterial chemoembolization for early-stage (BCLC A) oligo-nodular hepatocellular carcinoma: meta-analysis 78
Alcoholic Etiology, Severity of Liver Disease, and Post-Transplant Adherence Are Correlated with Worse Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) in Liver Transplant Candidates 77
Angiogenesis and Hepatocellular Carcinoma: From Molecular Mechanisms to Systemic Therapies 76
Surveillance as determinant of long-term survival in non-transplanted hepatocellular carcinoma patients 76
Severity of systemic inflammation is the main predictor of ACLF and bleeding in patients with acutely decompensated cirrhosis 75
Circulating microrna-21 and microrna-122 as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization 74
Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival 73
Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative Analysis 72
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma 72
Bacterial Infections in End-Stage Liver Disease: Implications for Liver Transplantation 71
Crosstalk between MicroRNAs and Oxidative Stress in Coeliac Disease 69
Haemostatic alterations in patients with cirrhosis and hepatocellular carcinoma: laboratory evidence and clinical implications 69
Eosinophilic esophagitis: from pathophysiology to management 68
Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges 66
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Strategies and Biomarkers Predicting Response and/or Resistance 66
Machine learning in liver transplantation: a tool for some unsolved questions? 65
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 64
BIOMARCATORI CIRCOLANTI E FATTORI CLINICI ASSOCIATI CON LA PROGNOSI NEI PAZIENTI CON CARCINOMA EPATOCELLULARE 64
Multiple hepatic cysts in an adult male 63
Systemic therapies for hepatocellular carcinoma: An evolving landscape 63
Eosinophilic esophagitis and biologics 62
Treatment of hepatocellular carcinoma with immune checkpoint inhibitors and applicability of first-line atezolizumab/bevacizumab in a real-life setting 61
Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment 60
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 56
Efficacy of immunotherapy in hepatocellular carcinoma: Does liver disease etiology have a role? 55
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care 54
Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCC 53
HIF-1α and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization 53
Somatic Copy Number Alterations in Circulating Cell-Free DNA as a Prognostic Biomarker for Hepatocellular Carcinoma: Insights from a Proof-of-Concept Study 50
Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma: A Real-life Multicentric Weighted Comparison 47
Characteristics and outcome of anti‐hepatitis D virus positive patients with hepatocellular carcinoma 46
Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma 44
A rare cause of painful hepatomegaly 40
Toward a more precise prognostic stratification in acute decompensation of cirrhosis: The Padua model 2.0 37
Patient journey in gastroesophageal reflux disease: real-world perspectives from Italian gastroenterologists, primary care physicians, and ENT specialists 29
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection 24
Totale 4.007
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.829
article - articoli 17.606
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.435
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021179 0 0 34 0 1 2 5 41 14 12 6 64
2021/2022371 9 22 11 16 10 41 53 45 18 20 42 84
2022/2023283 62 9 26 26 42 32 6 16 33 5 21 5
2023/2024372 21 40 41 22 13 45 71 13 17 20 31 38
2024/20251.537 12 96 63 46 130 48 90 93 168 115 274 402
2025/20261.188 361 448 379 0 0 0 0 0 0 0 0 0
Totale 4.007